Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:
Consumer OTC Drugs

Mead Johnson

This article was originally published in The Tan Sheet

  • News
  • The Tan Sheet

Executive Summary

TV and print ads in parenting magazines for new EnfaGrow Toddler Foods and Enfamil Enriched Cereal For Baby are slated to break in January. The infant formula brand extensions began shipping Nov. 1 nationwide to stores such as Toys R Us and Kmart. The EnfaGrow products include Nutritional Cracker Bites, Nutritional Cookie Bars, Nutritional Oatmeal and Nutritional Milk Flavoring in banana and vanilla flavors. The Enfamil Enriched Cereal comes in four flavors: rice, rice and bananas, rice with apples, bananas and yogurt, and mixed grains. A Nov. 21 FSI offers 75[cents] coupons for both lines. Mead Johnson also dropped an FSI the same day for Viactiv Calcium Chews for women with a 55[cents] coupon and $2 refund offer. The line now includes a caramel flavor in addition to the original milk chocolate and mochaccino

Table

View full table

Topics

Tags:
Consumer OTC Drugs
Latest Headlines

Mismatch Between Growing Vaccine Pipeline and CDC’s ACIP Capacity

Keeping Track: Two Breakthrough Oncologics, Another Antibiotic Clear US FDA Along With Pfizer’s Hemophilia B Gene Therapy

Priority Review Vouchers: Tropical Disease Candidates Wait Years For FDA Action On Qualifying List

Pink Sheet Podcast: US FDA Biosimilar Strategy, Gene Therapy Accelerated Approvals, FDA v. Partisan Politics

See All
UsernamePublicRestriction

Register

PS090613

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By